Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
Luca SorrentinoMarcello GuaglioLuigi BattagliaGiuliano BonfantiMarco VitellaroAlessandro Cesa BianchiMassimo MilioneFiliberto BelliPublished in: International journal of colorectal disease (2019)
CRT should be considered for cT3N0 patients, but its timing (neoadjuvant vs. adjuvant) seems not to affect the disease-free survival in the present cohort of patients.
Keyphrases
- rectal cancer
- locally advanced
- end stage renal disease
- ejection fraction
- newly diagnosed
- early stage
- free survival
- computed tomography
- peritoneal dialysis
- magnetic resonance imaging
- radiation therapy
- squamous cell carcinoma
- image quality
- dual energy
- positron emission tomography
- contrast enhanced
- atrial fibrillation
- cancer therapy
- percutaneous coronary intervention